10 Jefferies Group Biomarin Pharmaceutical - Registered Shares Trades
Jefferies Group's position in Biomarin Pharmaceutical - Registered Shares is currently worth $369 Thousand. That's 0.01% of their equity portfolio (806th largest holding). The first Biomarin Pharmaceutical - Registered Shares trade was made in Q4 2022. Since then Jefferies Group bought shares four more times and sold shares on five occasions. The investor's estimated purchase price is $414 Thousand, resulting in a loss of 11%.
News about Biomarin Pharmaceutical Inc. - Registered Shares and Jefferies Group
Hedge Fund and Insider Trading News: Carl Icahn, Steve Cohen, Ray Dalio, Balyasny Asset Management, Elliott Management, Coatue Management, American Water Works Company Inc (AWK), Life Time Group Holdings, Inc (LTH), and More
Icahn’s Investment Fund Plunges Deeper Into the Red (Institutional Investor) Steve Cohen’s Latest Donations Support Student-Managed Funds (Observer.com) Acti...
Neuberger Berman Group LLC Increases Stake in BioMarin Pharmaceutical Inc. by 1.3% during Q4 2022
On June 8, 2023, Neuberger Berman Group LLC reported a 1.3% increase in their stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN). The firm disclosed in its ...
BioMarin Pharmaceutical Inc. (BMRN) Q4 2022 Earnings Call Transcript
BioMarin Pharmaceutical Inc. (NASDAQ:NASDAQ:BMRN) Q4 2022 Results Conference Call February 28, 2023 4:30 PM ETCompany ParticipantsTraci McCarty - Group VP, I...
BioMarin Pharmaceutical (NASDAQ:BMRN) Price Target Increased to $115.00 by Analysts at SVB Leerink
BioMarin Pharmaceutical (NASDAQ:BMRN) had its target price hoisted by SVB Leerink from $112.00 to $115.00 in a research note issued to investors on Monday mo...